Recently ranked · United States
Last recorded placements from this show’s chart history. These are not current rankings.
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Diabetes Discourse, try…
Latest episodes
-
Addressing Cardiovascular Risk in Prediabetes: Why Earlier Action Matters
October 7, 2026 · 5 minGuest: John W. Ostrominski, MD, MPH Prediabetes may signal more than the future development of diabetes; it can also provide an opportunity to identify and address cardiovascular risk earlier. Here to recap his presentation at the…
-
Enhancing the Metabolic Benefits of GLP-1s with Diet and Exercise
October 2, 2026 · 3 minGuest: Laura Chiavaroli, PhD How might diet and exercise influence metabolic outcomes among patients taking GLP-1 medicines? To find out, we recently spoke with Dr. Laura Chiavaroli, who discussed this topic at the 2026 European…
-
Investigating Alpha-Beta Cell Proximity and T-Cell Interactions in T1D
October 2, 2026 · 3 minGuest: Vira Kravets, PhD Cellular interactions within pancreatic islets may provide important insights into the early stages and pathogenesis of type 1 diabetes (T1D). Tune in to hear Dr. Vira Kravets share research she presented at…
-
Investigating Beta Cell Dysfunction and Immune Activity in Early T1D
October 2, 2026 · 4 minGuest: Edward Phelps, PhD Residual beta cells may persist after a type 1 diabetes (T1D) diagnosis, but how well do they continue to function? Tune in to hear Dr. Edward Phelps discuss research he presented at the 2026 European…
-
Unanswered Questions in T1D: What Immunology and Islet Research Can Tell Us
October 2, 2026 · 3 minGuest: Edward Phelps, PhD Despite advances in type 1 diabetes (T1D) research, key questions remain about disease progression, immune mechanisms, and the optimal timing of intervention. Here to explore how immunology and islet research…
Show 7 more episodesShow fewer episodes
-
Hypertension in T2D: Understanding the AACE Recommendations
August 25, 2026 · 3 minGuest: Scott D. Isaacs, MD FACP, FACE For patients with type 2 diabetes, the latest American Association of Clinical Endocrinology (AACE) guidance supports tailoring hypertension treatment to individual risk profiles. Dr. Scott Isaacs…
-
Survodutide in Obesity: Insights from SYNCHRONIZE-1
June 17, 2026 · 5 minGuest: Carel le Roux, MBChB, MSC, FRCP, FRCPath, PhD New findings from the SYNCHRONIZE-1 trial reveal that survodutide's impact extends beyond weight reduction, with a demonstrated decrease in liver fat and meaningful improvements…
-
Addressing Cost-Related Medication Non-Adherence in Diabetes
June 9, 2026 · 5 minGuest: Kimberly Narain, MD, MPH, PhD Cost-related medication nonadherence remains a significant but often hidden barrier to effective diabetes care, with out-of-pocket costs preventing patients from accessing essential therapies. Dr…
-
Understanding Residual Cardiovascular Risk in CKD and T2D
June 9, 2026 · 5 minGuest: John W. Ostrominski, MD, MPH Despite advances in glycemic management, blood pressure control, lipid lowering, and disease-modifying therapies, patients with chronic kidney disease (CKD) and type 2 diabetes continue to face…
-
Digital Innovation in Diabetes Prevention for Older Adults
June 8, 2026 · 13 minHost: Steve Jackson, PharmD Guest: Souptik Barua, PhD Guest: Emily Johnston, MPH, PhD Can older adults successfully engage with telehealth, wearable technology, and digital health tools to prevent type 2 diabetes? In this…
-
Addressing Unmet Needs in Type 1 Diabetes Management
June 3, 2026 · 3 minGuest: Javier Morales, MD, FACP, FACE From proactive screening to once-weekly insulin, the treatment landscape for type 1 diabetes is evolving rapidly. Join Dr. Javier Morales to hear about current and emerging care strategies in…
-
Incretin-Based Advances in Obesity and T2D Care
June 3, 2026 · 4 minGuest: Javier Morales, MD, FACP, FACE For patients with obesity and type 2 diabetes (T2D), emerging incretin-based therapies that target multiple metabolic pathways are producing meaningful weight-loss outcomes. To learn more about…

Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom